Tech Company Financing Transactions
ALung Technologies Funding Round
ALung Technologies secured a $15.8 million Series B funding round on 9/11/2013. Investors included Allos Ventures, Birchmere Ventures and BlueTree Allied Angels.
Transaction Overview
Company Name
Announced On
9/11/2013
Transaction Type
Venture Equity
Amount
$15,800,000
Round
Series B
Investors
Allos Ventures (Lead Investor) (John McIlwraith)
Proceeds Purpose
The proceeds will primarily support ongoing global commercialization of the Hemolung Respiratory Assist System (RAS), a new extracorporeal carbon dioxide removal (ECCO2R) system that provides a dialysis-like alternative or supplement to mechanical ventilation.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2500 Jane St. 1
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Not Recorded
Overview
ALung provides Respiratory Dialysis with the Hemolung RAS, a simple, minimally invasive extracorporeal carbon dioxide removal (ECCO2R) system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter DeComo
Chief Financial Officer
David Haffner
VP - Engineering
Jeremy Kimmel
VP - General Counsel
Rachel Allen
VP - Operations
Joseph Argyros
VP - Regulatory Affairs
Frank Falcione
VP - Regulatory Affairs
Laura Lund
Browse more venture capital transactions:
Prev: 9/11/2013: Alafair Biosciences venture capital transaction
Next: 9/11/2013: CanDiag venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs